Akers is trading at $3.89, it went up with $0.04 from $3.85. This is due to the hopes that investors still hold on Executive Chairman Christopher Schreiber's words that there should be an update later at the end of April concerning the "second stage in protein expression." The company recently obtained all coronavirus antigens that have been selected for the vaccine candidate and have been working on the purification and post-expression processing before being allowed to launch tests on humans. So investors are holding on hope hence the reason why it is going up today.